Published in Neurogastroenterol Motil on November 27, 2014
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome. Intern Med (2017) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci (1988) 4.65
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science (2003) 4.58
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Alterations in 5-HT1B receptor function by p11 in depression-like states. Science (2006) 3.55
Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol (2003) 2.59
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology (2002) 2.52
Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum (2004) 2.33
A unique central tryptophan hydroxylase isoform. Biochem Pharmacol (2003) 2.23
Organization of the human serotonin transporter gene. J Neural Transm Gen Sect (1994) 1.97
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology (2011) 1.88
Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci (1996) 1.76
Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol (2004) 1.75
Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci (2009) 1.62
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut (2009) 1.58
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol (2011) 1.41
Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol (2002) 1.40
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.36
Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol (2007) 1.32
Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol (2008) 1.29
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol (2008) 1.22
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome. Digestion (2008) 1.15
Reliability, discriminant and predictive validity of the Zung Self-rating Depression Scale. Psychol Rep (1985) 1.11
Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol (1997) 1.10
Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients. Aliment Pharmacol Ther (1999) 1.09
Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med (2007) 1.07
Support for the involvement of TPH2 gene in affective disorders. Mol Psychiatry (2004) 1.06
ZBP-89 regulates expression of tryptophan hydroxylase I and mucosal defense against Salmonella typhimurium in mice. Gastroenterology (2013) 1.00
SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol (2012) 1.00
Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther (1999) 0.97
Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry (2005) 0.97
Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci (2011) 0.97
Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil (2012) 0.96
Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil (2010) 0.92
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. Aliment Pharmacol Ther (2008) 0.91
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil (2010) 0.89
Lactose malabsorption diagnosed by 50-g dose is inferior to assess clinical intolerance and to predict response to milk withdrawal than 25-g dose in an endemic area. J Gastroenterol Hepatol (2013) 0.85
Targeting serotonin synthesis to treat irritable bowel syndrome. Gastroenterology (2011) 0.84
Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol (2013) 0.84
A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan. Alcohol Clin Exp Res (2005) 0.83
Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers. Psychiatry Res (2010) 0.82
Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population. J Med Genet (2006) 0.82
Influence of human tryptophan hydroxylase 2 N- and C-terminus on enzymatic activity and oligomerization. J Neurochem (2007) 0.82
Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood. Psychiatr Genet (2012) 0.79
Psychotherapeutics and serotonin agonists and antagonists. J Clin Gastroenterol (2005) 0.77
A common TPH2 haplotype regulates the neural processing of a cognitive control demand. Am J Med Genet B Neuropsychiatr Genet (2012) 0.76
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
The International Neuroblastoma Pathology Classification (the Shimada system). Cancer (1999) 6.42
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology (2010) 3.35
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer (1999) 3.28
New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg (1979) 3.20
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol (1994) 2.89
Bni1p implicated in cytoskeletal control is a putative target of Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J (1996) 2.87
Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension (1996) 2.79
Rom1p and Rom2p are GDP/GTP exchange proteins (GEPs) for the Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J (1996) 2.76
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev (1997) 2.68
Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation (1993) 2.56
Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol (2001) 2.51
A new murine model of accelerated senescence. Mech Ageing Dev (1981) 2.40
Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc (2001) 2.30
Isolation and characterization of a novel actin filament-binding protein from Saccharomyces cerevisiae. Oncogene (1998) 2.27
Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol (1994) 2.23
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res (1993) 2.20
Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study. Neurology (2011) 2.17
Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol (1990) 2.11
Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther (2013) 2.08
Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation (1995) 2.02
Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care (1992) 1.97
Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest (1993) 1.97
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol (2003) 1.86
Ultrasonographic assessment of inflammatory bowel disease. Am J Gastroenterol (1992) 1.84
Proteinuria and clinical outcomes after ischemic stroke. Neurology (2012) 1.84
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology (1994) 1.80
C-reactive protein, ESR, and klebsiella in ankylosing spondylitis. Ann Rheum Dis (1980) 1.80
Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue. Hepatology (1992) 1.77
Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol (1998) 1.77
Acute cervical cord injury without fracture or dislocation of the spinal column. J Neurosurg (2000) 1.75
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 1.75
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res (1996) 1.74
The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes (1996) 1.72
Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet (2000) 1.71
Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology (2011) 1.71
Reactivity of cerebral blood flow to carbon dioxide in hypertensive patients: evaluation by the transcranial Doppler method. J Hypertens (1994) 1.70
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol (1994) 1.69
Simulated and observed variability in ocean temperature and heat content. Proc Natl Acad Sci U S A (2007) 1.68
Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem (1994) 1.68
Interaction of Bnr1p with a novel Src homology 3 domain-containing Hof1p. Implication in cytokinesis in Saccharomyces cerevisiae. J Biol Chem (1998) 1.68
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res (1995) 1.64
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest (1997) 1.64
Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke (1993) 1.63
Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem (1994) 1.62
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology (1993) 1.61
Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation (1991) 1.60
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
NOS and COX isoforms and abnormal microvessel responses to CO2 and H+ in hyperoxia-injured lungs. Eur Respir J (2002) 1.54
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Clinicopathological features of gastric mucosa-associated lymphoid tissue lymphoma: a comparison with diffuse large B-cell lymphoma without a mucosa-associated lymphoid tissue lymphoma component. J Gastroenterol Hepatol (2001) 1.53
Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int (2001) 1.52
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes (1995) 1.51
'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res (1991) 1.51
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension (1998) 1.50
Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res (2001) 1.50
A brief sexual barrier intervention for women living with AIDS: acceptability, use, and ethnicity. J Urban Health (2001) 1.49
Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol (1998) 1.49
Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology (2006) 1.49
A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry. Am J Obstet Gynecol (1989) 1.49
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet (2001) 1.48
Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem (1994) 1.48
Fish glucocorticoid receptor with splicing variants in the DNA binding domain. FEBS Lett (1996) 1.47
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry (1994) 1.46
Cobblestone monolayer cells from human omental adipose tissue are possibly mesothelial, not endothelial. In Vitro Cell Dev Biol (1989) 1.46
Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand (2010) 1.45
2-Methylthio-1,4-naphthoquinone, a unique sulfur-containing quinone from a thermophilic hydrogen-oxidizing bacterium, Hydrogenobacter thermophilus. J Bacteriol (1987) 1.45
Acute gastric anisakiasis: 28 cases during the last 10 years. Dig Dis Sci (1996) 1.45
Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation (2001) 1.45
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer (2001) 1.44
Isolated left coronary ostial stenosis as the sole arterial involvement in Takayasu's disease. J Intern Med (1992) 1.43
Cranial fasciitis of childhood: a case report. Eur J Pediatr Surg (1993) 1.43
Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature (1994) 1.43
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg (2009) 1.43
ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol (2001) 1.43
Circadian variation of haemodynamics in patients with essential hypertension: comparison between early morning and evening. J Hypertens (1994) 1.42
Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes (1994) 1.42
Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma. Dig Liver Dis (2006) 1.41
Relation of absence of ST reelevation immediately after reperfusion and success of reperfusion with myocardial salvage. Am J Cardiol (1997) 1.41
Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res (1991) 1.41
Ultrasonic evaluation of early carotid atherosclerosis. Stroke (1990) 1.40
Risk factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching. Liver Transpl (2001) 1.40
Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun (1994) 1.39
Crush and imprint cytology of subependymoma: a case report. Acta Cytol (2001) 1.39
Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med (1998) 1.39
Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart (2000) 1.39
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther (2002) 1.38